# South Korea Digital Diabetes Management Market > South Korea Digital Diabetes Management Market Research Report By Technology (Mobile Applications, Wearable Devices, Remote Monitoring Solutions, Telehealth Services), By Product Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End-user (Patients, Healthcare Professionals, Pharmacies, Diabetes Care Centers), andBy Functionality (Data Management, Patient Engagement, Clinical Decision Support, Remote Patient Monitoring) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.58% - **2024:** $ 135.75 Million - **2025:** $ 152.83 Million - **2035:** $ 500.04 Million - **Key Players:** Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US) **Report ID:** MRFR/HC/48846-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-digital-diabetes-management-market-50603 --- ## Market Summary ## **South Korea Digital Diabetes Management Market Overview** As per MRFR analysis, the South Korea Digital Diabetes Management Market Size was estimated at 267.3 (USD Million) in 2023.The South Korea Digital Diabetes Management Market is expected to grow from 308.1(USD Million) in 2024 to 1,665 (USD Million) by 2035. The South Korea Digital Diabetes Management Market CAGR (growth rate) is expected to be around 16.577% during the forecast period (2025 - 2035). **Key South Korea Digital Diabetes Management Market Trends Highlighted** The rising incidence of diabetes in the population is fuelling a demand boom in the South Korean digital diabetes management market. Due to shifting dietary and lifestyle choices, diabetes has one of the highest rates in the world. As a result, healthcare professionals and tech businesses are realizing more and more how important digital solutions are to effectively manage diabetes. The government's significant emphasis on healthcare innovation, especially in digital health technology, as part of its comprehensive healthcare strategy, which aims to improve health outcomes and increase patient involvement, is one of the main factors driving the market. This encouraging legislative framework encourages cooperation between public health organizations and the commercial sector, hastening the creation of cutting-edge diabetes control tools and applications. The use of machine learning (ML) and artificial intelligence (AI) in diabetes treatment has become increasingly popular in recent years. By evaluating enormous volumes of patient data, these technologies allow for more individualised treatment plans, improved patient adherence to treatment programs, and more precise blood sugar level predictions. Furthermore, the growing popularity of wearable technology is revolutionizing diabetes care by enabling real-time health monitoring and immediate feedback via linked platforms. Additionally, there is a lot of potential in the field of telemedicine, especially in rural areas where access to healthcare may be limited. By encouraging smart healthcare systems, the South Korean government improves patient convenience and care continuity by creating new opportunities for remote monitoring and consultations. As diabetes education programs expand, patients and healthcare professionals are becoming more interested in utilizing these digital technologies, which are significantly enhancing the standard of diabetes care in South Korea. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Digital Diabetes Management Market Drivers** Increasing Prevalence of Diabetes The South Korea [Digital Diabetes Management](../../../reports/digital-diabetes-management-market-7527) Market is witnessing substantial growth due to the rising prevalence of diabetes in the region. According to the Korea Diabetes Association, approximately 5.4 million people are currently living with diabetes in South Korea, representing around 10.5% of the adult population. This escalating number indicates a critical need for effective diabetes management solutions. Moreover, the government of South Korea has prioritized public health policies that emphasize chronic disease management, including diabetes, leading to an increased adoption of digital health technologies. The Ministry of Health and Welfare in South Korea has also implemented initiatives that promote digital health applications and platforms aimed at improving diabetes care. The collaboration between technology companies and healthcare providers to develop user-friendly diabetes management apps will further drive market growth. Technological Advancements in Digital Health The ongoing advancements in technology, particularly in the field of digital health, are significantly influencing the South Korea Digital Diabetes Management Market. Innovations such as continuous glucose monitoring, mobile health applications, and telemedicine are becoming increasingly popular among diabetic patients. Data from the Korea National Health Insurance Service indicates that telemedicine usage has surged by 50% since the onset of the COVID-19 pandemic, highlighting the public's growing acceptance of remote healthcare solutions. Companies like Samsung and LG are actively involved in developing cutting-edge diabetes management technologies, which further accelerates the market growth. The South Korean government's support for Research and Development (R&D) in health technology is also encouraging innovation, with funding allocated to projects aimed at improving digital health services. Government Initiatives and Health Policies The South Korean government continues to support the South Korea Digital Diabetes Management Market through various initiatives and health policies aimed at improving healthcare access and quality. The Health Care Promotion Law, enacted in 2022, encourages the use of digital health technologies for chronic disease management, including diabetes. This law aims to integrate digital solutions into the mainstream healthcare system, providing better management options for patients. Moreover, the Ministry of Health and Welfare has launched public awareness campaigns to educate the population about diabetes prevention and management, fostering an environment that is conducive to the adoption of digital health solutions. The collaborative efforts between governmental bodies and private sectors are expected to enhance the overall landscape of diabetes care in South Korea. Growing Consumer Demand for Personalized Healthcare Solutions There is a growing consumer demand for personalized healthcare solutions, which significantly impacts the South Korea Digital Diabetes Management Market. South Korean consumers are increasingly looking for tailored health management options that cater to their specific needs. A survey conducted by the Korean Consumer Agency reveals that approximately 75% of South Koreans are interested in apps that provide personalized health insights and management plans based on individual health data. Companies such as Hims and Rigi are capitalizing on this demand by offering platforms that provide personalized diabetes management solutions. Additionally, as more individuals prioritize proactive health management, the uptake of digital diabetes tools that offer customizable features is expected to boost market growth. **South Korea Digital Diabetes Management Market Segment Insights** **Digital Diabetes Management Market Technology Insights** The South Korea Digital Diabetes Management Market within the Technology segment is witnessing significant evolution, driven by the increased prevalence of diabetes and an aging population. With advancements in mobile technology, mobile applications emerge as a crucial tool in diabetes management by providing users with the ability to track their blood glucose levels, dietary habits, and exercise routines. These applications significantly contribute to patient engagement and empowerment, promoting self-management tailored to individual needs. Simultaneously, wearable devices have gained traction in the market by enabling continuous monitoring of physiological parameters, empowering patients to receive real-time feedback and alerts regarding their glucose levels. This technology integration is crucial in preventing complications associated with diabetes, enhancing patient safety, and improving overall health outcomes. Remote monitoring solutions leverage connected technologies to facilitate data exchange between patients and healthcare providers, improving access to care while allowing for timely interventions as needed. This also eases the burden on healthcare facilities, optimizing resource utilization. Telehealth services have further revolutionized diabetes management by allowing patients to consult healthcare professionals without needing to travel. This convenience is particularly significant in contemporary South Korea, where individuals increasingly favor digital interactions and remote healthcare access due to busy lifestyles and urbanization challenges. The ongoing trend towards digital transformation in healthcare aligns with government initiatives aimed at promoting health technology adoption and improving healthcare delivery systems. Moreover, the evolving landscape of the South Korea Digital Diabetes Management Market indicates a surge in innovation within these technological areas. With growing awareness and emphasis on preventive healthcare, these technologies are invaluable in addressing the rising demand for effective diabetes management solutions. Thus, the Technology segment within the market holds critical importance, helping to shape the future of diabetes care while focusing on improving patient outcomes and enhancing the quality of life for millions affected by diabetes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Digital Diabetes Management Market Product Type Insights** The South Korea Digital Diabetes Management Market is witnessing robust growth across various product types, with each category contributing uniquely to diabetes care. Blood Glucose Monitors are pivotal in aiding patients to track their glucose levels, thus enabling better management of diabetes; they are integral for individuals aiming for regular monitoring and control. Insulin Delivery Devices, including both pens and pumps, offer improved delivery methods that enhance patient compliance and comfort, promoting better glycemic control. Continuous Glucose Monitoring Systems are gaining traction due to their ability to provide real-time blood glucose data without the need for frequent finger pricking, empowering patients to make informed decisions about their health more effectively. Furthermore, Diabetes Management Software plays a crucial role by allowing users to analyze their data and trends, thereby facilitating personalized care plans. Each of these segments reflects a growing trend toward technology-driven management solutions, responding to the increasing prevalence of diabetes in South Korea and the demand for innovative healthcare technologies. As the South Korean government pushes for advanced healthcare solutions, these segments are likely to see significant developments and enhancements, shaping the future landscape of diabetes management in the region. **Digital Diabetes Management Market****End-user****Insights** The End-user segment of the South Korea Digital Diabetes Management Market showcases a diverse landscape comprising Patients, Healthcare Professionals, Pharmacies, and Diabetes Care Centers. Patients significantly drive the adoption of digital diabetes management solutions as they actively seek tools for better glycemic control and improved quality of life. Healthcare Professionals play a crucial role in recommending these management tools, often utilizing digital platforms to enhance patient engagement and therapy adherence. Pharmacies contribute by offering technological advancements that assist patients in managing their conditions, establishing themselves as essential partners in diabetes care. Meanwhile, Diabetes Care Centers serve as vital hubs for delivering personalized care and education, leveraging digital tools to streamline treatment plans and monitor patient progress. This segment's diversity underscores the collaborative approach necessary for effective diabetes management, highlighting both individual and institutional roles in supporting patient health. The overall growth of the South Korea Digital Diabetes Management Market stems from increasing interest in health technology, the rising prevalence of diabetes, and a collective effort to enhance patient outcomes through digital solutions. **Digital Diabetes Management Market Functionality Insights** The South Korea Digital Diabetes Management Market functionality segment plays a crucial role in enhancing diabetes care and improving patient outcomes. This segment encompasses several components, with Data Management, Patient Engagement, Clinical Decision Support, and Remote Patient Monitoring being the vital aspects. Data Management focuses on the systematic collection and analysis of patient data, ensuring healthcare providers make informed decisions. With the rise of chronic diseases, Patient Engagement tools have gained importance, fostering adherence to treatment plans through motivational prompts and educational resources. Clinical Decision Support systems provide healthcare professionals with evidence-based insights, facilitating timely and effective interventions. Remote Patient Monitoring is particularly significant, as it allows continuous tracking of patients' health metrics, enabling timely interventions and reducing emergency visits. The increasing prevalence of diabetes in South Korea, driven by lifestyle changes and aging populations, underscores the need for innovative solutions that these functionalities offer. Moreover, government initiatives promoting digital health technology further bolster the expansion of this market segment, making it essential for addressing the healthcare challenges posed by diabetes effectively. As these functionalities evolve, they not only enhance the quality of care but also pave the way for more personalized and efficient diabetes management solutions in South Korea. **South Korea Digital Diabetes Management Market Key Players and Competitive Insights:** The South Korea Digital Diabetes Management Market is witnessing significant growth, characterized by the increasing prevalence of diabetes and the rising adoption of technology to improve patient outcomes. This market is marked by a variety of digital solutions that encompass continuous glucose monitoring systems, mobile applications for diabetes management, data analytics tools, and telehealth services. With the South Korean government actively supporting health technology innovations and increasing patient awareness about the self-management of diabetes, the competitive landscape is rapidly evolving. Key players in the market are leveraging advanced technology, forming strategic partnerships, and investing in research and development to enhance their product offerings and cater to the diverse needs of patients. The integration of artificial intelligence and big data analytics is also expected to play a pivotal role in shaping the future of diabetes management solutions in the region. Bayer has established a notable presence in the South Korea Digital Diabetes Management Market, leveraging its extensive portfolio of healthcare solutions. Known for its innovative approach, Bayer has focused on developing digital therapeutics and devices that empower patients to manage diabetes effectively. The company's strengths lie in its strong brand reputation, comprehensive research capabilities, and an established distribution network, which facilitates easy access to its products. Bayer's commitment to enhancing patient education and support through digital platforms further solidifies its position in the market. The company's initiatives aimed at promoting healthy lifestyles and diabetes awareness in South Korea reinforce its dedication to improving health outcomes and driving customer loyalty in an increasingly competitive environment. Dexcom has emerged as a leading player in the South Korea Digital Diabetes Management Market with its cutting-edge continuous glucose monitoring (CGM) systems. With a strong emphasis on technology and user-friendly solutions, Dexcom offers real-time glucose data, enabling patients to make informed decisions regarding their diabetes management. The company's key products focus on high-accuracy sensors and mobile apps that sync data seamlessly, enhancing patient engagement. Dexcom's strengths include its innovative product development, which addresses the specific needs of South Korean consumers, and its strategic partnerships with local healthcare providers to enhance market penetration. Recent mergers and acquisitions have further strengthened Dexcom's market position, allowing it to integrate advanced technologies and expand its service offerings in South Korea. Through relentless pursuit of innovation and commitment to enhancing diabetes management experiences, Dexcom continues to play a vital role in shaping the future landscape of digital diabetes care in the region. **Key Companies in the South Korea Digital Diabetes Management Market Include:** **South Korea Digital Diabetes Management****Market****Developments** The South Korea Digital Diabetes Management Market has seen significant developments recently, particularly with advancements in technology and strategic partnerships among major players. In October 2023, LG Electronics announced an initiative to enhance its diabetes management solutions through collaborations with healthcare professionals aimed at improving patient engagement and outcomes. Concurrently, Abbott Diabetes Care launched a new version of their continuous glucose monitoring system tailored for South Korean consumers, reflecting the rising demand for innovative solutions. Over the past couple of years, Glooko gained traction with its holistic diabetes management platform, integrating seamlessly with various diabetes devices, which has broadened its reach among healthcare providers in South Korea.  In June 2023, the South Korean government also increased funding for diabetes management initiatives, further fostering growth in the sector. Companies like Medtronic and Dexcom continue to invest in Research and Development, enhancing their product offerings to meet local market needs effectively. While there have not been publicly reported mergers or acquisitions among the major companies in this period, the market's overall valuation continues to rise, driven by an increasing prevalence of diabetes and a growing emphasis on digital health solutions. **South Korea Digital Diabetes Management Market Segmentation Insights** **Digital Diabetes Management Market Technology****Outlook** **Digital Diabetes Management Market Product Type****Outlook** **Digital Diabetes Management Market****End-****user****Outlook** **Digital Diabetes Management Market Functionality****Outlook** ## Market Drivers ### Increasing Prevalence of Diabetes The rising incidence of diabetes in South Korea is a primary driver for the digital diabetes-management market. Recent statistics indicate that approximately 13.4% of the adult population is affected by diabetes, a figure that continues to grow. This alarming trend necessitates innovative management solutions, prompting healthcare providers and technology firms to invest in digital platforms. The digital diabetes-management market is expected to expand as patients seek effective tools for monitoring and controlling their condition. Moreover, the South Korean government has initiated various health campaigns aimed at diabetes awareness, further stimulating demand for digital solutions. As the population ages and lifestyle-related diabetes cases increase, the market is likely to see a surge in adoption of digital management tools, which could enhance patient outcomes and reduce healthcare costs. ### Government Initiatives and Support Government initiatives in South Korea play a crucial role in promoting the digital diabetes-management market. The Ministry of Health and Welfare has launched several programs aimed at integrating technology into diabetes care, including subsidies for digital health solutions. These initiatives not only encourage the development of innovative applications but also facilitate access for patients. For instance, the government has allocated approximately $50 million to support research and development in digital health technologies. Such financial backing is likely to foster collaboration between tech companies and healthcare providers, enhancing the overall ecosystem. As a result, the digital diabetes-management market is poised for growth, with increased investment leading to more effective and user-friendly solutions for diabetes management. ### Rising Health Awareness Among Consumers There is a notable increase in health awareness among South Korean consumers, which significantly impacts the digital diabetes-management market. As individuals become more informed about the risks associated with diabetes, they are actively seeking tools to manage their health. This shift in consumer behavior is reflected in the growing demand for mobile applications and digital platforms that offer personalized health insights. Market data suggests that the adoption rate of health-related apps has surged by over 30% in the past year. This trend indicates a strong willingness among consumers to embrace technology for health management. Consequently, the digital diabetes-management market is likely to benefit from this heightened awareness, as more individuals turn to digital solutions for effective diabetes control. ### Technological Advancements in Healthcare Technological advancements are transforming the healthcare landscape in South Korea, thereby driving the digital diabetes-management market. Innovations such as artificial intelligence, machine learning, and data analytics are being integrated into diabetes management solutions, enhancing their effectiveness. For instance, AI-driven applications can analyze patient data to provide personalized recommendations, improving adherence to treatment plans. The market is witnessing a surge in the development of smart devices that connect with mobile applications, allowing for real-time monitoring of blood glucose levels. This integration of technology not only empowers patients but also enables healthcare providers to offer more tailored care. As these advancements continue to evolve, the digital diabetes-management market is expected to expand, offering more sophisticated tools for diabetes management. ### Growing Demand for Remote Patient Monitoring The demand for remote patient monitoring solutions is escalating in South Korea, significantly influencing the digital diabetes-management market. With the increasing prevalence of chronic diseases, healthcare providers are seeking efficient ways to monitor patients outside traditional clinical settings. Digital tools that facilitate remote monitoring allow for continuous tracking of blood glucose levels and other vital signs, enabling timely interventions. Recent surveys indicate that over 60% of healthcare professionals support the use of digital solutions for managing diabetes remotely. This trend is likely to drive the adoption of digital diabetes-management tools, as both patients and providers recognize the benefits of proactive health management. Consequently, the market is expected to grow as more healthcare systems integrate remote monitoring capabilities into their diabetes care protocols. ## Future Outlook The [Digital Diabetes Management Market](https://www.marketresearchfuture.com/reports/digital-diabetes-management-market-7527) is projected to grow at a 12.58% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising health awareness. **New opportunities:** - Development of AI-driven predictive analytics tools for personalized diabetes management. - Expansion of telehealth services to enhance patient engagement and monitoring. - Integration of wearable devices with mobile applications for real-time data tracking. By 2035, the market is expected to achieve substantial growth, driven by innovation and increased consumer adoption. ## Segment Insights ### By Technology: Glucose Monitoring Devices (Largest) vs. Diabetes Management Software (Fastest-Growing) In the South Korea digital diabetes-management market, Glucose Monitoring Devices hold the largest share, showing a significant preference among users due to their critical role in managing glucose levels. On the other hand, Diabetes Management Software is rapidly gaining traction, reflecting the ongoing shift towards more integrated digital solutions for diabetes care. The growth in these segments is driven by increasing awareness of diabetes management and advancements in technology. Glucose Monitoring Devices benefit from innovations like continuous glucose monitoring, while Diabetes Management Software thrives on enhanced data analytics and accessibility through various platforms. Additionally, mobile applications are supplementing these devices, creating a comprehensive ecosystem for diabetes management. Technology: Glucose Monitoring Devices (Dominant) vs. Diabetes Management Software (Emerging) Glucose Monitoring Devices dominate the South Korea digital diabetes-management market due to their essential function in real-time monitoring of blood glucose levels, leading to better health outcomes for users. These devices have evolved with features like smartphone integration and cloud data storage, allowing for seamless tracking and sharing of information. On the other hand, Diabetes Management Software has emerged as an innovative tool, providing personalized insights and analytics that enhance diabetes care. This software is becoming increasingly popular as users seek more sophisticated ways to manage their condition, making it a vital component of the digital health landscape in South Korea. ### By Product Type: Continuous Glucose Monitors (Largest) vs. Smart Insulin Pens (Fastest-Growing) The South Korea digital diabetes-management market exhibits a diverse product landscape, with Continuous Glucose Monitors holding the largest market share. These devices have gained significant traction among users due to their ability to provide real-time glucose readings, which facilitate better diabetes management. Smart Insulin Pens are also notable, rapidly increasing their presence as more individuals recognize their advantages, including dosage precision and ease of use in daily routines. Growth trends within this segment show a consistent rise driven by technological advancements and increasing awareness of diabetes care among the population. The proliferation of Diabetes Management Platforms and Wearable Devices is also shaping the market dynamics by integrating lifestyle monitoring with glucose control, leading to improved health outcomes. This integration is enhancing user engagement and satisfaction, propelling further adoption across various demographics. Continuous Glucose Monitors (Dominant) vs. Smart Insulin Pens (Emerging) Continuous Glucose Monitors stand out as the dominant force within the South Korea digital diabetes-management market due to their comprehensive capabilities, offering continuous tracking and alert systems that empower users to manage their glucose levels effectively. In contrast, Smart Insulin Pens represent an emerging segment that is rapidly gaining attention for their innovative features such as Bluetooth connectivity and automatic dose calculation, which appeal particularly to tech-savvy users. Together, these products create a robust ecosystem, enhancing the overall diabetes management experience by combining real-time monitoring with precise medication delivery. As awareness grows, the demand for both product categories is expected to rise, fostering a more proactive approach to diabetes care. ### By End User: Individuals (Largest) vs. Healthcare Providers (Fastest-Growing) Within the South Korea digital diabetes-management market, the distribution among user segments showcases Individuals as the largest end user group, holding a significant proportion of the market share. Healthcare Providers follow as a crucial segment, facilitating patient care and adopting technologies that enhance their services. Pharmaceutical Companies and Research Organizations, although integral to the ecosystem, currently hold a smaller share in comparison to these primary groups, indicating a skew towards direct consumer engagement in the market. As the market evolves, growth trends are predominantly driven by the increasing prevalence of diabetes among Individuals, which drives demand for digital management solutions. The commitment of Healthcare Providers to integrate these solutions into their practices is emerging as a key growth factor, particularly as they seek to improve patient outcomes and engagement. Hence, the emphasis on accessible, easy-to-use digital solutions is attracting attention in the healthcare sector, making Providers the fastest-growing segment. Individuals (Dominant) vs. Pharmaceutical Companies (Emerging) Individuals in the South Korea digital diabetes-management market represent a dominant force, leveraging digital tools for personal health management and monitoring. Their access to and engagement with these solutions create a robust demand for innovative products tailored to individual needs. In contrast, Pharmaceutical Companies are identified as an emerging segment, increasingly recognizing the necessity to provide digital healthcare solutions alongside their medicinal products. They are making strategic investments to enhance their digital offerings, aiming to integrate with personal diabetes management tools and create synergies between medication and digital health applications, thus positioning themselves to meet the changing expectations of patients and healthcare professionals alike. ### By Distribution Channel: Online Sales (Largest) vs. Pharmacies (Fastest-Growing) In the South Korea digital diabetes-management market, the distribution of sales across channels reveals that online sales maintain the largest share, driven by increasing consumer preference for convenience and the rise of e-commerce platforms. Pharmacies represent a significant portion of the market as well, serving as accessible points for diabetes management products and services. The growth trends in this segment highlight a robust shift towards online sales as consumers exhibit a growing inclination to purchase diabetes management solutions through digital platforms. Pharmacies are emerging as the fastest-growing channel, fueled by their expanding role in healthcare delivery and the increasing integration of diabetes management solutions into pharmacy services. Online Sales (Dominant) vs. Pharmacies (Emerging) Online sales have established themselves as the dominant channel for diabetes management products, characterized by their extensive reach and convenience for patients seeking timely solutions. The ease of access to information and products online enhances user engagement while fostering a preference for digital transactions. Conversely, pharmacies are considered an emerging channel, reflecting their ability to adapt to consumer needs through personalized service and professional advice. The integration of technology within pharmacies, such as telepharmacy and online prescription services, positions them to capitalize on the growing demand for diabetes management, thereby increasing their market relevance. ## Competitive Benchmarking The digital diabetes-management market in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and increasing prevalence of diabetes. Key players such as Abbott (US), Medtronic (US), and Dexcom (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Abbott (US) has positioned itself as a leader in continuous glucose monitoring (CGM) technology, while Medtronic (US) emphasizes integrated diabetes management solutions. Dexcom (US) continues to innovate with its CGM systems, enhancing user experience and data integration capabilities. Collectively, these strategies foster a competitive environment that prioritizes technological innovation and user-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for diverse offerings and competitive pricing, yet the influence of major companies remains significant, shaping market trends and consumer preferences. In October Abbott (US) announced the launch of its latest CGM system, which integrates advanced AI algorithms to provide real-time insights and predictive analytics for users. This strategic move is likely to enhance patient engagement and adherence to diabetes management protocols, positioning Abbott as a frontrunner in the digital diabetes space. The integration of AI into their product line suggests a commitment to leveraging technology for improved health outcomes. In September Medtronic (US) expanded its partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration aims to streamline diabetes management for patients, particularly in rural areas, where access to healthcare may be limited. By integrating telehealth solutions, Medtronic is likely to improve patient outcomes and expand its reach in the South Korean market. In August Dexcom (US) launched a new feature in its CGM app that allows users to share glucose data with healthcare providers in real-time. This strategic enhancement not only improves communication between patients and providers but also positions Dexcom as a leader in patient-centric diabetes management solutions. The ability to share data seamlessly could lead to more personalized treatment plans and better health outcomes. As of November current trends in the digital diabetes-management market include a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing service delivery. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological innovation, user experience, and supply chain reliability. Companies that prioritize these aspects are likely to gain a competitive edge in the increasingly complex market. ## Recent News & Developments The South Korea Digital Diabetes Management Market has seen significant developments recently, particularly with advancements in technology and strategic partnerships among major players. In October 2023, LG Electronics announced an initiative to enhance its diabetes management solutions through collaborations with healthcare professionals aimed at improving patient engagement and outcomes. Concurrently, Abbott Diabetes Care launched a new version of their continuous glucose monitoring system tailored for South Korean consumers, reflecting the rising demand for innovative solutions. Over the past couple of years, Glooko gained traction with its holistic diabetes management platform, integrating seamlessly with various diabetes devices, which has broadened its reach among healthcare providers in South Korea.  In June 2023, the South Korean government also increased funding for diabetes management initiatives, further fostering growth in the sector. Companies like Medtronic and Dexcom continue to invest in Research and Development, enhancing their product offerings to meet local market needs effectively. While there have not been publicly reported mergers or acquisitions among the major companies in this period, the market's overall valuation continues to rise, driven by an increasing prevalence of diabetes and a growing emphasis on digital health solutions. ## Report Scope | MARKET SIZE 2024 | 135.75(USD Million) | | --- | --- | | MARKET SIZE 2025 | 152.83(USD Million) | | MARKET SIZE 2035 | 500.04(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.58% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott (US), Medtronic (US), Roche (CH), Dexcom (US), Ascensia Diabetes Care (DE), Insulet Corporation (US), Tandem Diabetes Care (US), Glooko (US) | | Segments Covered | Technology, Product Type, End User, Distribution Channel | | Key Market Opportunities | Integration of artificial intelligence in digital diabetes-management market enhances personalized patient care and treatment adherence. | | Key Market Dynamics | Rising adoption of mobile health applications enhances patient engagement in digital diabetes-management solutions. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the current valuation of the digital diabetes-management market in South Korea?** A: The market valuation was $135.75 Million in 2024. **Q: What is the projected market size for the digital diabetes-management market by 2035?** A: The projected valuation for 2035 is $500.04 Million. **Q: What is the expected CAGR for the digital diabetes-management market during the forecast period 2025 - 2035?** A: The expected CAGR is 12.58%. **Q: Which companies are the key players in the digital diabetes-management market?** A: Key players include Abbott, Medtronic, Roche, Dexcom, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, and Glooko. **Q: What are the main segments of the digital diabetes-management market?** A: The main segments include Technology, Product Type, End User, and Distribution Channel. **Q: What was the valuation of glucose monitoring devices in 2024?** A: The valuation for glucose monitoring devices ranged from $30.0 Million to $120.0 Million. **Q: How much is the diabetes management software segment valued at in 2024?** A: The diabetes management software segment was valued between $40.0 Million and $150.0 Million. **Q: What is the projected valuation for diabetes management platforms by 2035?** A: The projected valuation for diabetes management platforms is expected to reach $200.0 Million. **Q: What is the distribution channel with the highest valuation in 2024?** A: The distribution channel with the highest valuation was specialized diabetes clinics, ranging from $40.75 Million to $160.04 Million. **Q: What is the expected growth trend for healthcare providers in the digital diabetes-management market?** A: The healthcare providers segment is projected to grow from $50.0 Million to $200.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-digital-diabetes-management-market-50603*